DD
Xlife Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| VERAXA Biotech AG | Portfolio Company | N/A |
| Alexipharm | Oncology (Targeted Toxins) | Pre-clinical |
| Alzheimer's Diagnostic Program | Alzheimer's Disease (Early Detection) | Discovery |
| saniva diagnostics GmbH | Parkinson's Disease Diagnostics | Not Specified |
Leadership Team at Xlife Sciences
OR
Oliver R. Baumann
CEO, Member of the Board of Directors
CV
Carl von Halem
CFO
DA
Dr. Alexander Zink
CSO
DF
Dr. Frank Plöger
Managing Director Xlife Sciences USA
DL
David L. Deck
President of the Board of Directors
MS
Mark S. Müller
Member of the Board of Directors
DN
Dr. Norbert Windhab
Member of the Board of Directors
PD
Prof. Dr. habil. Michael B. Klein
Chairman of the Advisory Board
PD
Prof. Dr. Hans-Georg Rammensee
Advisory Board, Immunology Expert
PD
Prof. Dr. Johannes Schumacher
Advisory Board, Human Genetics Expert